Cargando…
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896746/ https://www.ncbi.nlm.nih.gov/pubmed/36732693 http://dx.doi.org/10.1186/s12876-022-02636-9 |
| _version_ | 1784882114394587136 |
|---|---|
| author | Rayer, Cassandra Nachury, Maria Bourreille, Arnaud Roblin, Xavier Peyrin-Biroulet, Laurent Viennot, Stephanie Flamant, Mathurin Laharie, David Caron, Bénédicte Dewitte, Marie Siproudhis, Laurent Fumery, Mathurin Bouguen, Guillaume |
| author_facet | Rayer, Cassandra Nachury, Maria Bourreille, Arnaud Roblin, Xavier Peyrin-Biroulet, Laurent Viennot, Stephanie Flamant, Mathurin Laharie, David Caron, Bénédicte Dewitte, Marie Siproudhis, Laurent Fumery, Mathurin Bouguen, Guillaume |
| author_sort | Rayer, Cassandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9896746 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98967462023-02-04 Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study Rayer, Cassandra Nachury, Maria Bourreille, Arnaud Roblin, Xavier Peyrin-Biroulet, Laurent Viennot, Stephanie Flamant, Mathurin Laharie, David Caron, Bénédicte Dewitte, Marie Siproudhis, Laurent Fumery, Mathurin Bouguen, Guillaume BMC Gastroenterol Correction BioMed Central 2023-02-02 /pmc/articles/PMC9896746/ /pubmed/36732693 http://dx.doi.org/10.1186/s12876-022-02636-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Rayer, Cassandra Nachury, Maria Bourreille, Arnaud Roblin, Xavier Peyrin-Biroulet, Laurent Viennot, Stephanie Flamant, Mathurin Laharie, David Caron, Bénédicte Dewitte, Marie Siproudhis, Laurent Fumery, Mathurin Bouguen, Guillaume Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title | Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title_full | Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title_fullStr | Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title_full_unstemmed | Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title_short | Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study |
| title_sort | correction: efficacy of ustekinumab, vedolizumab, or a second anti-tnf agent after the failure of a first anti-tnf agent in patients with crohn’s disease: a multicentre retrospective study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896746/ https://www.ncbi.nlm.nih.gov/pubmed/36732693 http://dx.doi.org/10.1186/s12876-022-02636-9 |
| work_keys_str_mv | AT rayercassandra correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT nachurymaria correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT bourreillearnaud correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT roblinxavier correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT peyrinbirouletlaurent correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT viennotstephanie correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT flamantmathurin correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT lahariedavid correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT caronbenedicte correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT dewittemarie correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT siproudhislaurent correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT fumerymathurin correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy AT bouguenguillaume correctionefficacyofustekinumabvedolizumaborasecondantitnfagentafterthefailureofafirstantitnfagentinpatientswithcrohnsdiseaseamulticentreretrospectivestudy |